https://stock.noler.com/us/stock/sangui-biotech-international-inc https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/accounts-receivable-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/accumulated-amortization-of-other-deferred-costs https://stock.noler.com/us/stock/sangui-biotech-international-inc/accumulated-depreciation-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/accumulated-oci-before-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/sangui-biotech-international-inc/additional-paid-in-capital https://stock.noler.com/us/stock/sangui-biotech-international-inc/adjustment-for-amortization https://stock.noler.com/us/stock/sangui-biotech-international-inc/advances-to-affiliate https://stock.noler.com/us/stock/sangui-biotech-international-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/sangui-biotech-international-inc/amended-reports-10-k https://stock.noler.com/us/stock/sangui-biotech-international-inc/amended-reports-10-q https://stock.noler.com/us/stock/sangui-biotech-international-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/sangui-biotech-international-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/sangui-biotech-international-inc/aoci https://stock.noler.com/us/stock/sangui-biotech-international-inc/basic-shares https://stock.noler.com/us/stock/sangui-biotech-international-inc/business-acquisition-purchase-price-allocation-notes-payable-and-long-term-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/sangui-biotech-international-inc/capital-expenditures https://stock.noler.com/us/stock/sangui-biotech-international-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-and-equivalents https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sangui-biotech-international-inc/commitments-and-contingencies https://stock.noler.com/us/stock/sangui-biotech-international-inc/common-stock-no-par-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/sangui-biotech-international-inc/common-stock-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/comprehensive-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/convertible-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/convertible-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/cost-of-goods-sold https://stock.noler.com/us/stock/sangui-biotech-international-inc/cost-of-revenue https://stock.noler.com/us/stock/sangui-biotech-international-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sangui-biotech-international-inc/current-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/current-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-carrying-amount https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-conversion-converted-instrument-rate https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-increase-decrease-other-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/sangui-biotech-international-inc/debtor-reorganization-items-gain-loss-on-settlement-of-other-claims-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-costs https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-finance-costs-ownshare-lending-arrangement-issuance-costs-adjustment https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-other-comprehensive-loss https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-impairment-losses https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-liabilities-deferred-expense-deferred-financing-costs https://stock.noler.com/us/stock/sangui-biotech-international-inc/deferred-tax-liabilities-derivatives https://stock.noler.com/us/stock/sangui-biotech-international-inc/defined-benefit-plan-foreign-currency-exchange-rate-changes-plan-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/depreciation https://stock.noler.com/us/stock/sangui-biotech-international-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/derivative-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/diluted-shares https://stock.noler.com/us/stock/sangui-biotech-international-inc/due-from-related-parties-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/due-to-related-parties-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sangui-biotech-international-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/fair-value-net-derivative-asset-liability-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/sangui-biotech-international-inc/financing-cash-flow https://stock.noler.com/us/stock/sangui-biotech-international-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/sangui-biotech-international-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/sangui-biotech-international-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/gain-loss-on-investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/sangui-biotech-international-inc/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/gain-loss-on-sale-of-interest-in-projects https://stock.noler.com/us/stock/sangui-biotech-international-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/gross-profit https://stock.noler.com/us/stock/sangui-biotech-international-inc/impairment-of-investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-from https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-from-attributable-to-noncontrolling-entity https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-from-before-interest-expense-interest-income-income-taxes-extraordinary-items-noncontrolling-interests-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-taxes-paid https://stock.noler.com/us/stock/sangui-biotech-international-inc/income-taxes-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-and-notes-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-customer-advances-and-deposits https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-derivative-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-derivative-assets-and-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-due-to-other-related-parties-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-inventory-for-long-term-contracts-or-programs https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-lease-acquisition-costs https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-notes-receivable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-notes-receivable-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-notes-receivables https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-operating-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-restricted-cash-and-investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-restricted-cash-and-investments-for-operating-activities https://stock.noler.com/us/stock/sangui-biotech-international-inc/increase-decrease-in-royalties-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/interest-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/interest-expense-on-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/interest-income-other https://stock.noler.com/us/stock/sangui-biotech-international-inc/interest-paid https://stock.noler.com/us/stock/sangui-biotech-international-inc/interest-paid-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/inventory https://stock.noler.com/us/stock/sangui-biotech-international-inc/inventory-adjustments https://stock.noler.com/us/stock/sangui-biotech-international-inc/investing-cash-flow https://stock.noler.com/us/stock/sangui-biotech-international-inc/investment-income-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/investments https://stock.noler.com/us/stock/sangui-biotech-international-inc/investments-in-and-advances-to-affiliates-at-fair-value-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/sangui-biotech-international-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/sangui-biotech-international-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/sangui-biotech-international-inc/lease-and-rental-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/sangui-biotech-international-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/sangui-biotech-international-inc/liabilities-noncurrent https://stock.noler.com/us/stock/sangui-biotech-international-inc/long-term-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/loss-in-period https://stock.noler.com/us/stock/sangui-biotech-international-inc/loss-on-contract-termination https://stock.noler.com/us/stock/sangui-biotech-international-inc/minority-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-cash-from https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-change-in-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-income-loss-allocated-to-general-partners https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/sangui-biotech-international-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/sangui-biotech-international-inc/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/sangui-biotech-international-inc/noncontrolling-interest-in-variable-interest-entity https://stock.noler.com/us/stock/sangui-biotech-international-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/sangui-biotech-international-inc/nonoperating-gains-losses https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-payable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-payable-related-parties-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-receivable-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/notes-receivable-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-before-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-foreign-currency-translation-adjustment-tax-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-net-of-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-other-net-of-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/oci-tax https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-cash-flow https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-expenses https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-liability https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sangui-biotech-international-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-current-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-expenses https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-income-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-noncash-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-noncash-income-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-nonoperating-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-notes-payable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-operating-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/other-than-temporary-impairment-credit-losses-recognized-in-earnings-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-for-fees https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-for-purchase-of-other-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-for-royalties https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-to-acquire-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-to-acquire-interest-in-joint-venture https://stock.noler.com/us/stock/sangui-biotech-international-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-shares-facts https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/sangui-biotech-international-inc/preferred-stock-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepaid-expense-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepaid-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepaid-taxes https://stock.noler.com/us/stock/sangui-biotech-international-inc/prepayment-fees-on-advances-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/pretax-income https://stock.noler.com/us/stock/sangui-biotech-international-inc/pretax-income-domestic https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-payments-for-long-term-loans-for-related-parties https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-sale-and-collection-of-notes-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-sale-of-foreclosed-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-sale-of-investment-projects https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-sale-of-notes-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/sangui-biotech-international-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sangui-biotech-international-inc/professional-fees https://stock.noler.com/us/stock/sangui-biotech-international-inc/profit-loss https://stock.noler.com/us/stock/sangui-biotech-international-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/sangui-biotech-international-inc/property-plant-equipment https://stock.noler.com/us/stock/sangui-biotech-international-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/sangui-biotech-international-inc/public-float https://stock.noler.com/us/stock/sangui-biotech-international-inc/related-party-deposit-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/sangui-biotech-international-inc/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/repayments-of-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/sangui-biotech-international-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/repayments-of-unsecured-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/research-and-development https://stock.noler.com/us/stock/sangui-biotech-international-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/retained-earnings https://stock.noler.com/us/stock/sangui-biotech-international-inc/revenue https://stock.noler.com/us/stock/sangui-biotech-international-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/sangui-biotech-international-inc/sales-revenue-net https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-10-k https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-10-q https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-10ksb https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-10qsb https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-8-k https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-def-14a https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-ntn-10k https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/sangui-biotech-international-inc/sec-filings-revoked https://stock.noler.com/us/stock/sangui-biotech-international-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/sangui-biotech-international-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/sangui-biotech-international-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/sangui-biotech-international-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/sangui-biotech-international-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/sangui-biotech-international-inc/share-price https://stock.noler.com/us/stock/sangui-biotech-international-inc/shareholders-equity https://stock.noler.com/us/stock/sangui-biotech-international-inc/shares-authorized https://stock.noler.com/us/stock/sangui-biotech-international-inc/shares-issued https://stock.noler.com/us/stock/sangui-biotech-international-inc/shares-issued-2 https://stock.noler.com/us/stock/sangui-biotech-international-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/sangui-biotech-international-inc/short-term-debt https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/sangui-biotech-international-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/sangui-biotech-international-inc/stockholders-equity-before-treasury-stock https://stock.noler.com/us/stock/sangui-biotech-international-inc/stockholders-equity-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/sangui-biotech-international-inc/stockholders-equity-not-allowable-for-net-capital https://stock.noler.com/us/stock/sangui-biotech-international-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/sangui-biotech-international-inc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/sangui-biotech-international-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sangui-biotech-international-inc/taxes-payable-current https://stock.noler.com/us/stock/sangui-biotech-international-inc/temporary-equity-foreign-currency-translation-adjustments https://stock.noler.com/us/stock/sangui-biotech-international-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/sangui-biotech-international-inc/total-assets https://stock.noler.com/us/stock/sangui-biotech-international-inc/total-liabilities https://stock.noler.com/us/stock/sangui-biotech-international-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sangui-biotech-international-inc/translation-adjustment-functional-to-reporting-currency-net-of-tax-change https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-carrying-basis https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-common-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-number-of-shares-held https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-reissued-at-lower-than-repurchase-price https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-value https://stock.noler.com/us/stock/sangui-biotech-international-inc/treasury-stock-value-retired-cost-method https://stock.noler.com/us/stock/sangui-biotech-international-inc/utb-increase-from-foreign-currency-translation https://stock.noler.com/us/stock/sangui-biotech-international-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/sangui-biotech-international-inc/weighted-average-number-of-shares-issued-basic https://stock.noler.com/us/stock/sangui-biotech-international-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted